The Fisher Wallace Stimulator® Approved by New York City Health and Hospitals Corporation

Portable Medical Device Treats Depression, Anxiety and Insomnia

News provided by

Mar 26, 2015, 10:00 ET

NEW YORK, March 26, 2015 /PRNewswire/ -- Fisher Wallace Laboratories today announced that its popular neurostimulation device, called the Fisher Wallace Stimulator®, has been approved by New York City Health and Hospitals Corporation (NYC HHC). New York City Health and Hospitals Corporation is comprised of eleven of New York City's largest hospitals, including Bellevue Hospital, Woodhull Hospital and Metropolitan Hospital. Woodhull Hospital is already using the device with patients.

The Fisher Wallace Stimulator® is FDA-Cleared for the treatment of depression, anxiety and insomnia. It works by stimulating the brain's production of serotonin and other key neurochemicals that are responsible for healthy mood and sleep. It causes no serious side effects and may be safely used with or without medication.

The non-invasive device delivers a gentle electrical current at patented frequencies to stimulate the brain to produce serotonin and other neurochemicals required for healthy mood and sleep. Multiple published studies prove the safety and effectiveness of the device, and it has been cleared by the FDA for the treatment of depression, anxiety and insomnia. The device also received a separate FDA clearance for treating chronic pain on the body. On June 12, 2014, the FDA announced its intention to fully approve the device through the reclassification process.

"The Fisher Wallace Stimulator is already prescribed by thousands of doctors in private practice for patients to treat depression, anxiety and insomnia at home, but this is the first hospital network to approve it," states Charles Fisher, Founder and President of Fisher Wallace Laboratories. "This approval makes our technology accessible to a vast patient population in need of effective alternatives to drug therapy."

Designed to be easily used by patients at home, the Fisher Wallace Stimulator® may be purchased through the Fisher Wallace website for $699. A $100 discount is provided to patients with Medicare or Medicaid. A prescription is required in the United States. The device is available for purchase over-the-counter in Canada and Europe.

"I have been using the Fisher Wallace device with select patients for about a year," states psychiatrist Karen Hopenwasser, MD. "Almost everyone has reported some improvement in sleep and mood. Most remarkable are the patients I have treated for more than a decade who are now experiencing greater relief than ever before."

About Fisher Wallace Laboratories
Fisher Wallace Laboratories manufactures the Fisher Wallace Stimulator®, a portable neurostimulation device cleared by the FDA for the treatment of depression, anxiety, insomnia and chronic pain.

Website: http://www.fisherwallace.com

Video - http://youtu.be/6EZn1FB7FEI

SOURCE Fisher Wallace Laboratories